Concepedia

Kateri A. Ahrendt

KA

12

Publications

2.2K

Citations

12

H-Index

1998

Active since

Affiliations

Array BioPharma (United States)(Current)

University of California, Berkeley

Colorado State University

Lawrence Berkeley National Laboratory

Kateri A. Ahrendt is an author at Array BioPharma (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

1998–2013

12

Publications

12

New Strategies for Organic Catalysis:  The First Highly Enantioselective Organocatalytic Diels−Alder Reaction

Kateri A. Ahrendt, Christopher J. Borths, David W. C. MacMillan · Journal of the American Chemical Society · 2000 · 1.6K citations

, , +12

Synthesis of a Tricyclic Mescaline Analogue by Catalytic C−H Bond Activation

Kateri A. Ahrendt, Robert G. Bergman, Jonathan A. Ellman · Organic Letters · 2003 · 98 citations

Annulation of Aromatic Imines via Directed C−H Bond Activation

Reema K. Thalji, Kateri A. Ahrendt, Robert G. Bergman et al. · The Journal of Organic Chemistry · 2005 · 93 citations

A Concise Asymmetric Synthesis of the ADE Fragment of Nakadomarin A

Kateri A. Ahrendt, Robert M. Williams · Organic Letters · 2004 · 79 citations

Pyrazolopyridine Inhibitors of B-Raf<sup>V600E</sup>. Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors

Steve Wenglowsky, Li Ren, Kateri A. Ahrendt et al. · ACS Medicinal Chemistry Letters · 2011 · 66 citations · Full text

Rows per page

1–5 of 12